Neoadjuvant docetaxel and estramustine chemotherapy in high-risk/locally advanced prostate cancer - Hussain M, Smith DC, El-Rayes BF, Du W, Vaishampayan U, Fontana J, Sakr W, Wood D, Division of Hematology/Oncology, Wayne State University and Barbara Ann Karmanos Cancer Institute, Detroit, MI. Urology 2003;61(4):774-780

Author: Chatta G.  

Publisher: Elsevier

ISSN: 1078-1439

Source: Urologic Oncology: Seminars and Original Investigations, Vol.21, Iss.6, 2003-11, pp. : 489-489

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content